192 related articles for article (PubMed ID: 3857939)
1. Tumour-associated antigen CA 125 in patients with ovarian cancer.
Heinonen PK; Tontti K; Koivula T; Pystynen P
Br J Obstet Gynaecol; 1985 May; 92(5):528-31. PubMed ID: 3857939
[TBL] [Abstract][Full Text] [Related]
2. The clinical significance of pre-operative serum CA 125 in ovarian cancer.
Cruickshank DJ; Fullerton WT; Klopper A
Br J Obstet Gynaecol; 1987 Jul; 94(7):692-5. PubMed ID: 2441738
[TBL] [Abstract][Full Text] [Related]
3. Serum CA 125 in ovarian pathology and its variation in ovarian carcinoma after integrated therapy.
Pansini F; Bellinazzi A; Rainaldi V; Santoiemma M; Lenzi B; Jacobs M; Mollica G; Bagni B
Gynecol Obstet Invest; 1986; 21(1):47-51. PubMed ID: 3005141
[TBL] [Abstract][Full Text] [Related]
4. Antigen CA125 in tumor tissue and serum from patients with adenocarcinoma of the ovary.
Maughan TS; Fish RG; Shelley M; Jasani B; Williams GT; Adams M
Gynecol Oncol; 1988 Jul; 30(3):342-6. PubMed ID: 2839394
[TBL] [Abstract][Full Text] [Related]
5. Expression of CEA, CA125, CA19-9 and human milk fat globule membrane antigen in ovarian tumours.
Macdonald F; Bird R; Stokes H; Russell B; Crocker J
J Clin Pathol; 1988 Mar; 41(3):260-4. PubMed ID: 3162916
[TBL] [Abstract][Full Text] [Related]
6. Cross-specificity of the tumour marker CA 19-9: a case of ovarian carcinoma with recurrent venous thrombosis.
Smellie S; Lambert M
Acta Gastroenterol Belg; 1987; 50(2):241-2. PubMed ID: 3481507
[No Abstract] [Full Text] [Related]
7. [CA 125 in the diagnosis and evaluation of the efficacy of the treatment of cancer of the ovaries].
Sagan DL; Chebotareva ED; Evtushenko GV
Med Radiol (Mosk); 1989 Jun; 34(6):39-42. PubMed ID: 2739519
[TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of circulating serum sialyl Tn antigen levels in patients with epithelial ovarian cancer.
Kobayashi H; Terao T; Kawashima Y
J Clin Oncol; 1991 Jun; 9(6):983-7. PubMed ID: 1851822
[TBL] [Abstract][Full Text] [Related]
9. Clinical use of CA 125 and its combination assay with other tumor marker in patients with ovarian carcinoma.
Negishi Y; Furukawa T; Oka T; Sakamoto M; Hirata T; Okabe K; Matayoshi K; Akiya K; Soma H
Gynecol Obstet Invest; 1987; 23(3):200-7. PubMed ID: 3474196
[TBL] [Abstract][Full Text] [Related]
10. The sebaceous gland antigen defined by the OM-1 monoclonal antibody is expressed at high density on the surface of ovarian carcinoma cells.
de Kretser TA; Thorne HJ; Jacobs DJ; Jose DG
Eur J Cancer Clin Oncol; 1985 Sep; 21(9):1019-35. PubMed ID: 2998800
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of CA-125 in patients with endometriosis: a preliminary report.
Giudice LC; Jacobs A; Pineda J; Bell CE; Lippmann L
Fertil Steril; 1986 Jun; 45(6):876-8. PubMed ID: 3458595
[TBL] [Abstract][Full Text] [Related]
12. Tumor-associated antigen Ca 125 before and during the treatment of ovarian carcinoma.
Kivinen S; Kuoppala T; Leppilampi M; Vuori J; Kauppila A
Obstet Gynecol; 1986 Apr; 67(4):468-72. PubMed ID: 3008051
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of serum CA 125 levels in the monitoring of ovarian cancer.
Vergote IB; Børmer OP; Abeler VM
Am J Obstet Gynecol; 1987 Jul; 157(1):88-92. PubMed ID: 2440307
[TBL] [Abstract][Full Text] [Related]
14. [Studies on the serum levels of a carbohydrate antigen 19-9 (CA 19-9) in patients with ovarian cancer].
Miyoshi T; Nishimura H; Ookura N; Morisaki H; Kobayashi H; Tasaki T; Ushijima H; Yakushiji M
Igaku Kenkyu; 1984 Dec; 54(8):796-800. PubMed ID: 6599577
[No Abstract] [Full Text] [Related]
15. An immunologic comparison between serous cystadenocarcinoma of the ovary and other human gynecologic tumors.
Bhattacharya M; Barlow JJ
Am J Obstet Gynecol; 1973 Nov; 117(6):849-53. PubMed ID: 4126800
[No Abstract] [Full Text] [Related]
16. Tumor antigen CA 125 as a marker of ovarian epithelial carcinoma.
Zanaboni F; Vergadoro F; Presti M; Gallotti P; Lombardi F; Bolis G
Gynecol Oncol; 1987 Sep; 28(1):61-7. PubMed ID: 2443433
[TBL] [Abstract][Full Text] [Related]
17. Combined immunohistochemical study of tissue polypeptide antigen and cancer antigen 125 in human ovarian tumours.
Ghazizadeh M; Sasaki Y; Oguro T; Aihara K; Tenjin H; Araki T
Histopathology; 1990 Aug; 17(2):123-8. PubMed ID: 2227836
[TBL] [Abstract][Full Text] [Related]
18. Improved specificity of the CA 125 enzyme immunoassay for ovarian carcinomas by use of the ratio of CA 125 to carcinoembryonic antigen.
Wu JT; Miya T; Knight JA; Knight DP
Clin Chem; 1988 Sep; 34(9):1853-7. PubMed ID: 2458203
[TBL] [Abstract][Full Text] [Related]
19. [CA 125 (cancer antigen 125), a new tumor associated antigen recognized by monoclonal antibody].
Suzuki H; Teshima K; Noda K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2719-23. PubMed ID: 6594978
[TBL] [Abstract][Full Text] [Related]
20. Elevated CA 125 serum levels and epithelial ovarian cancer metastatic to retroperitoneal lymph nodes.
Finkler NJ; Kapnick SJ; Griffiths CT; Knapp RC
Gynecol Oncol; 1988 Mar; 29(3):356-60. PubMed ID: 3162223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
